Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
12/7/2022
Updated
12/8/22, 9:37 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership